Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Published byDaniel Harmon Modified over 6 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro"— Presentation transcript:

1 Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.2
Figure 1 Four-step evaluation of donors before transplantation employed at the author's institution Figure 1 | Four-step evaluation of donors before transplantation employed at the author's institution. *Lab work includes advanced thrombophilia workup. ‡Liver biopsy to assess steatosis is performed in potential donors with a BMI >28 kg/m2 and suggestive imaging results. Fisher, R. A. (2017) Living donor liver transplantation: eliminating the wait for death in end‑stage liver disease? Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Download ppt "Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro"

Similar presentations

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 Exosome composition

Figure 2 Exosome composition
Figure 5 Dendritic cells in liver inflammation

Figure 5 Dendritic cells in liver inflammation
Figure 4 Activation of clopidogrel via cytochrome P450

Figure 4 Activation of clopidogrel via cytochrome P450
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 7 Treatment algorithm for perianal fistulizing disease

Figure 7 Treatment algorithm for perianal fistulizing disease
Figure 6 Injection of mesenchymal stem cells in perianal fistulas

Figure 6 Injection of mesenchymal stem cells in perianal fistulas
Figure 1 Patients cured of HCV infection

Figure 1 Patients cured of HCV infection
Figure 2 A stage-based approach to the treatment of NAFLD

Figure 2 A stage-based approach to the treatment of NAFLD
Figure 7 Management algorithm for patients with ACLF

Figure 7 Management algorithm for patients with ACLF
Figure 1 Gut microorganisms at the intersection of several diseases

Figure 1 Gut microorganisms at the intersection of several diseases
Figure 5 Lipid droplet consumption

Figure 5 Lipid droplet consumption
Figure 4 Simple perianal fistula

Figure 4 Simple perianal fistula
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 2 The microbiome–gut–brain axis

Figure 2 The microbiome–gut–brain axis
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Figure 1 Organs involved in coeliac-disease-associated autoimmunity
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Figure 1 Biosimilar development process

Figure 1 Biosimilar development process

Similar presentations

Ads by Google